
### [Orphanet:459530](http://www.orpha.net/ORDO/Orphanet_459530)
**Label:** Genetic primary lymphedema

**Subclasses:** [Orphanet:33001](http://www.orpha.net/ORDO/Orphanet_33001) (Lymphedema-distichiasis syndrome), [Orphanet:2526](http://www.orpha.net/ORDO/Orphanet_2526) (Microcephaly-lymphedema-chorioretinopathy syndrome), [Orphanet:69088](http://www.orpha.net/ORDO/Orphanet_69088) (Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome), [Orphanet:79452](http://www.orpha.net/ORDO/Orphanet_79452) (Milroy disease), [Orphanet:3226](http://www.orpha.net/ORDO/Orphanet_3226) (Deafness-lymphedema-leukemia syndrome), [Orphanet:2136](http://www.orpha.net/ORDO/Orphanet_2136) (Hennekam syndrome), [Orphanet:79319](http://www.orpha.net/ORDO/Orphanet_79319) (MPI-CDG), [Orphanet:89844](http://www.orpha.net/ORDO/Orphanet_89844) (Lissencephaly syndrome, Norman-Roberts type), [Orphanet:69735](http://www.orpha.net/ORDO/Orphanet_69735) (Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome), 

**Corr. equiv. classes:** [OMIM:607823](http://purl.obolibrary.org/obo/OMIM_607823), [OMIM:602579](http://purl.obolibrary.org/obo/OMIM_602579), [Orphanet:79319](http://www.orpha.net/ORDO/Orphanet_79319), [OMIM:153100](http://purl.obolibrary.org/obo/OMIM_153100), [OMIM:247440](http://purl.obolibrary.org/obo/OMIM_247440), [OMIM:300301](http://purl.obolibrary.org/obo/OMIM_300301), [Orphanet:69088](http://www.orpha.net/ORDO/Orphanet_69088), [OMIM:613480](http://purl.obolibrary.org/obo/OMIM_613480), [Orphanet:89844](http://www.orpha.net/ORDO/Orphanet_89844), [OMIM:153400](http://purl.obolibrary.org/obo/OMIM_153400), [OMIM:137940](http://purl.obolibrary.org/obo/OMIM_137940), [OMIM:152950](http://purl.obolibrary.org/obo/OMIM_152950), [Orphanet:69735](http://www.orpha.net/ORDO/Orphanet_69735), [OMIM:616006](http://purl.obolibrary.org/obo/OMIM_616006), [Orphanet:2136](http://www.orpha.net/ORDO/Orphanet_2136), [OMIM:235510](http://purl.obolibrary.org/obo/OMIM_235510), [Orphanet:2526](http://www.orpha.net/ORDO/Orphanet_2526), [OMIM:614038](http://purl.obolibrary.org/obo/OMIM_614038), [Orphanet:33001](http://www.orpha.net/ORDO/Orphanet_33001), [OMIM:611944](http://purl.obolibrary.org/obo/OMIM_611944), [Orphanet:79452](http://www.orpha.net/ORDO/Orphanet_79452), [OMIM:615907](http://purl.obolibrary.org/obo/OMIM_615907), [OMIM:257320](http://purl.obolibrary.org/obo/OMIM_257320), [Orphanet:3226](http://www.orpha.net/ORDO/Orphanet_3226), 

**Class expressions from DL-Learner:**

- [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) 57.77%
- [HP:0000499](http://purl.obolibrary.org/obo/HP_0000499) (Abnormality of the eyelashes) and [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) and [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 55.80%
- [HP:0000499](http://purl.obolibrary.org/obo/HP_0000499) (Abnormality of the eyelashes) and [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) 53.32%
- [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) 51.26%
- [HP:0000315](http://purl.obolibrary.org/obo/HP_0000315) (Abnormality of the orbital region) and [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) 49.70%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) 48.74%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) 47.62%
- [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 44.47%
- [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) and [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) 44.15%
- [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 43.90%
- [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 43.45%
- [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 43.12%
- [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 43.12%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 39.97%
- Thing 39.95%


